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Introduction 
The Faroe Islands are located quite far from the European continent and from industrial sources of 
polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs). However, the 
Faroese population may be exposed to these substances through contaminated food, via goods and 
products in their homes, and in their work environment. High trophic level marine species, 
including pilot whale and seabirds, such as fulmars, have been shown to accumulate high 
concentrations of organohalogen substances (OHS) like PCBs and PBDEs 1-3. Possibly due to 
dietary differences, wide differences exist in regard to PCB exposures among the Faroese. In a birth 
cohort from 1987, milk pools contained relatively high PCB concentrations between 1.9-2.5 µg/g 
lipid weight (l.w.) 4. In another cohort from 1994, serum from pregnant Faroese women was 
analyzed for PCB and OH-PCBs, with results ranging from 0.15 to 22 µg/g l.w. and 0.02 to 1.8 
µg/g l.w., respectively 5.  
 
In a time trend study for PBDEs and PCBs in human milk from Sweden from the early 1970s to 
1997, the PBDE concentrations showed a significant increase 6 while the PCB levels showed a 
decrease7. Human milk samples from 1997 to 2000 indicate a decrease for the PBDEs, mainly due 
to reduced concentrations of BDE-47 8. A similar trend has been seen in human milk from Japan 9. 
In Norway, PBDE in human milk increased from 1986 to 2001, with similar concentration levels as 
reported in Sweden and Japan 10. In the United States the PBDE levels reported in human milk are 
about 4 times higher than those seen in Europe and Japan 11,12.  
 
The aim of the present study was to determine PBDE and PCB concentrations in a temporal trend 
study with samples from 1987-1999 in human milk samples from the Faroe Islands.  
 
 
Material and Methods 
Samples: Mother-child pair cohorts were generated in 1987, 1994-1995 and 1998-1999, and milk 
was sampled consecutively during a short period at Landssjukrahusiδ in Tórshavn, Faroe Islands 
for analysis for major PCB congeners. Based on these results, samples were selected to represent 
the full range of PCB exposures and stored milk was retrieved for analysis. Pooled samples 
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containing equal amounts of milk from each mother and each pool consisted of 10 mothers. Three 
pooled milk samples from 1987, 1994-1995 and 1998-1999 and 9 individual samples from 1998-
1999 were analyzed for the major PBDE and PCB congeners.  
 
Chemicals: The individual PBDE congeners were synthesized in house 13 and the PCB congeners 
(numbered according to Ballschmiter et al. 14) were purchased from Larodan Fine Chemicals AB, 
Malmö, Sweden. The reference compounds used for quantifications in the present study are shown 
in Table 1. All solvents were of the highest available commercial grade. 
 
Instruments: The PBDE analysis was performed by gas chromatography/mass spectrometry 
(GC/MS), a Finnigan TSQ 700 instrument coupled with a Varian 3400 gas chromatograph and a 
DB-5HT capillary column (15 m x 0.25 mm i.d., 0.1 µm film thickness, J & W Scientific, Folsom, 
CA, USA). The transfer line temperature was set at 270oC and the ion source temperature was 
200oC. Helium was used as carrier gas (head pressure 3 psi) and methane as reagent gas at 5.6 torr. 
On-column injections were made using a septum equipped temperature programmable injector 
programmed from 60oC, 180oC/min, to 320oC. The oven temperature was programmed from 80oC 
(1 min) with 15oC/min to 300oC (16 min). PBDE congeners were quantified using bromide ions 
formed by electron capture negative ion chemical ionization (ECNI) with a primary electron energy 
of 70eV. Selected ion monitoring (SIM) was carried out for both bromide isotopes, m/z 79 and 81 
15.  
 
The PCB analysis was performed on a Varian 3400 gas chromatograph, equipped with a Varian 
8200 autosampler , an electron capture detector (ECD) and a split-splittless injector operated in the 
splitless mode. Hydrogen was used as carrier gas and nitrogen as make-up gas. A DB-5 column 
(30m x 0.25 mm internal diameter and 0.25 µm film thickness J & W Scientific, Folsom, CA, 
USA) was used. The column temperature was 80oC (2 min), 10oC/min, to 300oC (10 min). The 
injector temperature was 250oC and the detector temperature 360oC. The data were collected using 
a PC-based ELDS Pro v2.0 system (Chromatograhic Data System AB, Stockhom, Sweden). 
 
Analysis: The extraction and clean-up procedure for the milk samples is a modified version of a 
method described elsewhere 16. In the extraction formic acid and diethyl ether is used instead of 
hydrochloric acid and methyl tert-butyl ether. Surrogate standards, BDE-77, BDE-138 and CB-200 
were added to the samples prior to extraction.  
 
Results and Discussion 
This is the first report of PBDEs in human milk from the Faroe Islands. The concentrations of four 
main PBDE congeners and the sum of these four are given in Table 1. The range of concentrations 
reported in this study are similar to those observed in the United Kingdom and in Germany, with 
average sPBDE concentrations of about 6-7 ng/g l.w. 17,18. The sPBDE results from Sweden and 
Japan are generally lower (down to about one-third) when compared to this study 8,9. 
 
The concentrations of the three main PCB congeners as well as the sPCB (CB-118, CB-153, CB-
105, CB-138, CB-187, CB-183, CB-128, CB-156, CB-180 and CB-170) of the pooled samples are 
given in Table 1. The PCB levels reported are considerably higher than these reported from other 
studies of human milk. For example, Swedish and Belgian concentrations in human milk are a 
factor of about 3-7 below the results presented here 7,19. The time trend observed in Sweden showed 
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a steady decrease of PCB in human milk, with the PCB concentration in 1997 reaching about 30 % 
of the one observed in 1972 7. At the Faroe Islands, the PCB concentration seems rather constant 
over the years, although a slightly declining trend may be present, although not conclusive based 
upon this study alone, c.f. Figure 1A and Table 1. 
 
 
Table 1. Concentrations (ng/g lipid weight) of PBDE and PCB congeners identified in human milk from the 
Faroe Islands. The samples were pooled with 10 mothers in each pool. sPBDE  is the sum of BDE -47, BDE-
99, BDE-100 and BDE-153 and sPCB is the sum of CB-118, CB-153, CB-105, CB-138, CB-187, CB-183, 
CB-128, CB-156, CB-180 and CB-170 
Year 1987 1994-1995 1998-1999 
No. of mothers 10 10 10 
BDE-47 0.5 1.2 1.7 
BDE-99 0.20 0.50 1.0 
BDE-100 0.25 0.60 1.0 
BDE-153 0.60 1.4 3.6 
sPBDE 1.5 3.6 7.2 
PCB-153 590 420 470 
PCB-138 500 370 420 
PCB-180 390 240 270 
sPCB 2300 1600 1800 
 
 
The PBDE congener profile in the Faroes is clearly different from results previously reported for 
human milk samples 8,9,12,17. In the present study, BDE-153 is the dominant congener, followed by 
BDE-47, BDE-100 and BDE-99 at all three points of time (Table 1). Elsewhere, BDE-47 is the 
most abundant congener followed by either BDE-99 or BDE-153 8,9,12,17. The BDE-153 
concentrations reported from the most recent Faroese samples (1998-1999) are about 6 times higher 
than those seen in Sweden and in a range similar to those reported from the United States 6,8,12.  
 
All PBDE congeners and consequently also the sPBDE show increasing concentrations in milk 
from Faroese women from 1987 to 1999 c.f. Figure 1B. The variability of sPBDE and sPCB 
concentrations is apparent from analyses of nine individual samples from the last cohort (1998-
1999).  The wide range between the highest and the lowest concentration (Figure 1A and 1B) could 
conceivably be due to differences in life style and dietary habits.  
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Figure 1. Three pooled milk samples from mother-child pairs generated in 1987, 1994-1995 and 1998-1999 
from the Faroe Islands and 9 individual samples from 1998-1999. A) sPCB concentration in µg/g lipid weight. 
(sum of CB-118, CB-153, CB-105, CB-138, CB-187, CB-183, CB-128, CB-156, CB-180 and CB-170). B) 
sPBDE concentration in ng/g lipid weight (sum of BDE -47, BDE-99, BDE-100 and BDE-153).  
 
 
The BDE-47 trend is in accordance with findings from Sweden c.f. Figure 2. On the other hand, the 
BDE-153 profile is different from the reports from Sweden, with considerably higher 
concentrations and a steeply increasing trend of the concentration 6,8. However, the development in 
PBDE concentrations during the most recent years is unknown, thus calling for additional analyses 
from this location.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. A time trend comparison between Sweden 8,20 and the present study. Three pooled milk samples 
from mother-child pairs generated in 1987, 1994-1995 and 1998-1999 from the Faroe Islands and 9 individual 
samples from 1998-1999.  
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Conclusions 
This study reports for the first time PBDEs in human milk from the Faroe Islands. A steep increase 
of PBDE concentrations is shown from 1987-1999. The PBDE pattern is different from the one 
reported from studies elsewhere, with BDE-153 as the dominant congener, rather than BDE-47 
otherwise being the most prevalent congener 6,8,10.The PBDE sources at this remote location are 
unknown, and the steep increase calls for further studies. 
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